Cargando…

Lack of Electrocardiographic Effects of Deucravacitinib in Healthy Subjects

Deucravacitinib is a novel, oral, selective inhibitor of the intracellular signaling kinase tyrosine kinase 2. This phase 1, randomized, partially double‐blind, 4‐period crossover study in healthy adults was conducted to determine whether deucravacitinib 12 mg (therapeutic dose) or 36 mg (suprathera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chimalakonda, Anjaneya, Singhal, Shalabh, Darbenzio, Raymond, Dockens, Randy, Marchisin, David, Banerjee, Subhashis, Girgis, Ihab G., Throup, John, He, Bing, Aras, Urvi, Murthy, Bindu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306920/ https://www.ncbi.nlm.nih.gov/pubmed/35182043 http://dx.doi.org/10.1002/cpdd.1056

Ejemplares similares

Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects
por: Jing, Shan, et al.
Publicado: (2023)

Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors
por: Chimalakonda, Anjaneya, et al.
Publicado: (2021)

First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2
por: Catlett, Ian M., et al.
Publicado: (2022)

Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis
por: Mease, Philip J, et al.
Publicado: (2022)

Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial
por: Morand, Eric, et al.
Publicado: (2022)

Deucravacitinib: First Approval
por: Hoy, Sheridan M.
Publicado: (2022)

Deucravacitinib for the Treatment of Psoriatic Disease
por: Lé, Ana Maria, et al.
Publicado: (2022)

Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial
por: Thaçi, Diamant, et al.
Publicado: (2022)

Modeling and Simulation of the Pharmacokinetics and Target Engagement of an Antagonist Monoclonal Antibody to Interferon‐γ–Induced Protein 10, BMS‐986184, in Healthy Participants to Guide Therapeutic Dosing
por: Cai, Weiguo, et al.
Publicado: (2020)

Deucravacitinib for the treatment of psoriatic arthritis: the evidence so far
por: Martins, Ana, et al.
Publicado: (2023)

Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis
por: Jin, Joy Q, et al.
Publicado: (2023)

Successful treatment of refractory subacute cutaneous lupus erythematosus with deucravacitinib
por: Bouché, Nicole, et al.
Publicado: (2023)

Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature
por: Potestio, Luca, et al.
Publicado: (2023)

Population Pharmacokinetic Analysis of BMS‐986166, a Novel Selective Sphingosine‐1‐Phosphate‐1 Receptor Modulator, and Exposure‐Response Assessment of Lymphocyte Counts and Heart Rate in Healthy Participants
por: Bihorel, Sébastien, et al.
Publicado: (2020)

The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study
por: Garonzik, Samira, et al.
Publicado: (2019)

Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
por: Oliel, Sarah, et al.
Publicado: (2023)

Evaluation of safety, pharmacokinetics, and pharmacodynamics of apixaban in pediatric subjects at risk of venous or arterial thrombotic disorder
por: Merali, Samira J., et al.
Publicado: (2023)

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
por: Armstrong, April W., et al.
Publicado: (2023)

Brugada-type Electrocardiographic Pattern Induced by Fever
por: Ozeke, Ozcan, et al.
Publicado: (2005)

Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
por: Armstrong, April W., et al.
Publicado: (2023)

Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-Analysis
por: Armstrong, April W., et al.
Publicado: (2023)

Fast and Sensitive Bioanalytical Method for the Determination of Deucravacitinib in Human Plasma Using HPLC-MS/MS: Application and Greenness Evaluation
por: Mahesh, Pottabattula, et al.
Publicado: (2023)

Temporal Variability in Electrocardiographic Indices in Subjects With Brugada Patterns
por: Lee, Sharen, et al.
Publicado: (2020)

Electrocardiographic “precordial pattern break sign” for posterior coronary venous system
por: Aras, Dursun, et al.
Publicado: (2018)

The efficacy and safety of tyrosine kinase 2 inhibitor deucravacitinib in the treatment of plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials
por: Qiu, Jingyue, et al.
Publicado: (2023)

Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults
por: Dos Santos, Reinaldo S., et al.
Publicado: (2023)

Classical electrocardiographic clues for left main coronary artery disease
por: Sen, Fatih, et al.
Publicado: (2016)

Lack of Influence of the Androgen Receptor Gene CAG-Repeat Polymorphism on Clinical and Electrocardiographic Manifestations of the Brugada Syndrome in Man
por: Mariani, S., et al.
Publicado: (2012)

Exercises in Electrocardiographic Interpretation
Publicado: (1942)

The Fundamentals of Electrocardiographic Interpretation
Publicado: (1937)

The Care of the Electrocardiograph in the Tropics
por: McRobert, G. R.
Publicado: (1930)

Electrocardiographic changes in Emphysema
por: Gupta, Puneet, et al.
Publicado: (2021)

Electrocardiographic imaging in the atria
por: Hernández-Romero, Ismael, et al.
Publicado: (2022)

Electrocardiographic lead reversals
por: Paul, Amal, et al.
Publicado: (2023)

Electrocardiographic data should be coupled with tissue-Doppler imaging and clinical follow-up evaluation to determine cardiac involvement in lichen planus
por: Canpolat, Uğur, et al.
Publicado: (2013)

Electrocardiographic Limb Leads Placement and Its Clinical Implication: Two Cases of Electrocardiographic Illustrations
por: Tung, Robert T.
Publicado: (2021)

The effect of Emblica officinalis diet on lifespan, sexual behavior, and fitness characters in Drosophila melanogaster
por: Pathak, Pankaj, et al.
Publicado: (2011)

Electrocardiographic abnormalities in treatment-naïve HIV subjects in south-east Nigeria
por: Okoye, Innocent Chukwuemeka, et al.
Publicado: (2017)

Clinical trial report: the electrocardiographic response to ajmaline provocation in healthy subjects
por: Ensam, B, et al.
Publicado: (2023)

Novel Volumetric Sub-region Segmentation in Brain Tumors
por: Banerjee, Subhashis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_55hj7a264h8dpn2t0i22qo93vo